Health Care Select Sector SPDR® ETF (XLV)

Add to Watchlists
Create an Alert
69.84 -0.18  -0.26% NYSE Arca Jan 20, 16:59 Delayed 2m USD
View Full Chart
XLV Price Chart

XLV Key Stats

Expense Ratio 0.14%
Share Class Assets Under Management 14.20B
30-Day Average Daily Volume Upgrade
Net Asset Value 70.07
Discount or Premium to NAV -0.07%
Turnover Ratio 8.00

XLV Performance

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 1.05% 2.60% 85
3M 0.53% 1.50% 45
6M -4.53% -1.31% 78
1Y -2.76% 4.95% 32
3Y 9.14% 6.21% 19
5Y 16.63% 16.37% 56
As of Jan. 19, 2017
Returns for periods of 1 year and above are annualized.

XLV Asset Allocation

Type % Net % Long % Short
Cash 0.30% 0.30% 0.00
Stock 99.70% 99.70% 0.00
Bond 0.00 0.00 0.00
Convertible 0.00 0.00 0.00
Preferred 0.00 0.00 0.00
Other 0.00 0.00 0.00
As of Jan. 18, 2017

XLV Region Exposure

Americas 100.0%
North America 100.0%
Latin America 0.00
Greater Europe 0.00
United Kingdom 0.00
Europe Developed 0.00
Europe Emerging 0.00
Africa/Middle East 0.00
Greater Asia 0.00
Japan 0.00
Australasia 0.00
Asia Developed 0.00
Asia Emerging 0.00
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00
As of Jan. 17, 2017
Region breakdown data is calculated by using the long position holdings of the portfolio.

XLV Stock Sector Exposure

Basic Materials 0.00
Communication Services 0.00
Consumer Cyclical 0.00
Consumer Defensive 0.00
Energy 0.00
Financial Services 0.00
Healthcare 97.58%
Industrials 1.83%
Real Estate 0.00
Technology 0.58%
Utilities 0.00
As of Jan. 18, 2017

XLV Stock Market Capitalization

Giant 52.90%
Large 36.28%
Medium 10.73%
Small 0.10%
Micro 0.00
As of Jan. 18, 2017

XLV Stock Style Exposure

Large Cap Value 27.16%
Large Cap Blend 26.46%
Large Cap Growth 35.55%
Mid Cap Value 0.96%
Mid Cap Blend 4.43%
Mid Cap Growth 5.33%
Small Cap Value 0.10%
Small Cap Blend 0.00
Small Cap Growth 0.00
As of Jan. 18, 2017
View More Holdings

XLV Top 10 Holdings

Symbol Name % Weight Price % Chg
JNJ Johnson & Johnson 11.54% 114.49 +0.25%
PFE Pfizer Inc 7.19% 31.79 +0.28%
MRK Merck & Co Inc 6.24% 62.55 +3.68%
UNH UnitedHealth Group Inc 5.60% 158.51 -0.12%
AMGN Amgen Inc 4.29% 154.64 +0.55%
MDT Medtronic PLC 3.86% 74.99 -0.41%
ABBV AbbVie Inc 3.71% 61.15 -0.37%
GILD Gilead Sciences Inc 3.52% 71.10 -0.66%
BMY Bristol-Myers Squibb Company 3.49% 49.54 -10.72%
CELG Celgene Corp 3.30% 112.70 -0.81%
As of Jan. 18, 2017
Advertisement

XLV One Page Reports

XLV Basic Info

Style
Equity Style Large Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Health
Fund Owner Firm Name SPDR State Street Global Advisors
Benchmark Index
S&P Health Care Select Sector TR USD
100.0%

XLV Manager Info

Name Tenure
Dwayne Hancock 0.00 yrs
Karl Schneider 1.92 yrs
Michael Feehily 5.92 yrs

XLV Net Fund Flows

1M -116.82M
3M 1.668B
6M 1.568B
YTD 394.29M
1Y 394.29M
3Y 3.148B
5Y 5.464B
10Y 6.875B
As of Dec. 31, 2016

XLV Risk Info

Beta (5Y) 0.942
Max Drawdown (All) 40.51%
Historical Sharpe (10Y) 0.7111
Historical Sortino (All) 0.6566
30-Day Rolling Volatility 9.40%
Daily Value at Risk (VaR) 1% (All) 3.05%
Monthly Value at Risk (VaR) 1% (All) 13.22%

XLV Fundamentals

Dividend Yield TTM (1-20-17) 1.58%
SEC Yield (6-2-16) 1.48%
Weighted Average PE Ratio 21.07
Weighted Average Price to Sales Ratio 1.616
Weighted Average Price to Book Ratio 3.340
Weighted Median ROE 22.28%
Weighted Median ROA 8.12%
Forecasted Dividend Yield 1.77%
Forecasted PE Ratio 17.74
Forecasted Price to Sales Ratio 1.576
Forecasted Price to Book Ratio 2.970
Number of Holdings 61
As of Jan. 18, 2017

XLV Growth Estimates

Forecasted 5 Yr Earnings Growth 9.89%
Forecasted Book Value Growth 10.10%
Forecasted Cash Flow Growth 6.28%
Forecasted Earnings Growth 8.32%
Forecasted Revenue Growth 10.23%
As of Jan. 18, 2017

XLV Comparables

Edit

XLV Attributes

Key Dates
Inception Date 12/16/1998
Last Annual Report Date 9/30/2016
Last Prospectus Date 9/2/2016
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

XLV Excel Add-In Codes

  • Name: =YCI("XLV","name")
  • Broad Asset Class: =YCI("XLV", "broad_asset_class")
  • Broad Category: =YCI("XLV", "broad_category_group")
  • Prospectus Objective: =YCI("XLV", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.